SEARCH

SEARCH BY CITATION

References

  • 1
    Suzue K, Reinherz EL, Koyasu S. Critical role of NK but not NKT cells in acute rejection of parental bone marrow cells in F1 hybrid mice. Eur J Immunol 2001; 31: 31473152.
  • 2
    Liu J, George T, Devora GA et al. Murine natural killer cells and hybrid resistance to hemopoietic cells in vivo. Methods Mol Biol 2000; 121: 6171.
  • 3
    Kumar V, George T, Yu YY, Liu J, Bennett M. Role of murine NK cells and their receptors in hybrid resistance. Curr Opin Immunol 1997; 9: 5256.
  • 4
    Lee LA, Sergio JJ, Sykes M. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation 1996; 61: 125132.
  • 5
    Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 1991; 349: 329331.
  • 6
    Tiberghien P, Longo DL, Wine JW, Alvord WG, Reynolds CW. Anti-asialo GM 1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: Evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood 1990; 76: 14191430.
  • 7
    Kean LS, Hamby K, Koehn B et al. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am J Transplant 2006; 6: 292304.
  • 8
    Westerhuis G, Maas WG, Willemze R, Toes RE, Fibbe WE. Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 2005; 106: 22152220.
  • 9
    Huang Y, Rezzoug F, Xu H et al. NK cells play a critical role in the regulation of class I-deficient hemopoietic stem cell engraftment: Evidence for NK tolerance correlates with receptor editing. J Immunol 2005; 175: 37533761.
  • 10
    Neipp M, Gammie JS, Exner BG et al. A partial conditioning approach to achieve mixed chimerism in the rat: Depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment. Transplantation 1999; 68: 369378.
  • 11
    Huang Y, Rezzoug F, Chilton PM, Grimes HL, Cramer DE, Ildstad ST. Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: A role for host NK cells in regulating HSC engraftment. Blood 2004; 104: 87380.
  • 12
    Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 16111618.
  • 13
    McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 2000; 28: 11811186.
  • 14
    Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 15651577.
  • 15
    Kawai T, Wee SL, Bazin H et al. Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates. Transplantation 2000; 70: 368374.
  • 16
    Gaudieri S, DeSantis D, McKinnon E et al. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun 2005; 6: 683690.
  • 17
    Anfossi N, Andre P, Guia S et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006; 25: 331342.
  • 18
    Eriksson M, Leitz G, Fallman E et al. Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets. J Exp Med 1999; 190: 10051012.
  • 19
    Held W, Roland J, Raulet DH. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature 1995; 376: 355358.
  • 20
    Moretta A, Bottino C, Vitale M et al. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996; 14: 619648.
  • 21
    Held W, Cado D, Raulet DH. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection. J Exp Med 1996; 184: 20372041.
  • 22
    Brooks AG, Posch PE, Scorzelli CJ, Borrego F, Coligan JE. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med 1997; 185: 795800.
  • 23
    Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD 94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J Exp Med 1998; 188: 18411848.
  • 24
    Salcedo M, Andersson M, Lemieux S, Van Kaer L, Chambers BJ, Ljunggren HG. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur J Immunol 1998; 28: 13151321.
  • 25
    Lohwasser S, Hande P, Mager DL, Takei F. Cloning of murine NKG2A, B and C: Second family of C-type lectin receptors on murine NK cells. Eur J Immunol 1999; 29: 755761.
  • 26
    Michaelsson J, Achour A, Salcedo M et al. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol 2000; 30: 300307.
  • 27
    Karre K. How to recognize a foreign submarine. Immunol Rev 1997; 155: 59.
  • 28
    Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005; 5: 201214.
  • 29
    Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 20972100.
  • 30
    Davies SM, Ruggieri L, DeFor T et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood 2002; 100: 38253827.
  • 31
    Farag SS, Bacigalupo A, Eapen M et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry. Biol Blood Marrow Transplant 2006; 12: 876884.
  • 32
    Moretta L, Bottino C, Pende D, Vitale M, Mingari MC, Moretta A. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol Lett 2005; 100: 713.
  • 33
    Bottino C, Castriconi R, Moretta L, Moretta A. Cellular ligands of activating NK receptors. Trends Immunol 2005; 26: 221226.
  • 34
    Stewart CA, Vivier E, Colonna M. Strategies of natural killer cell recognition and signaling. Curr Top Microbiol Immunol 2006; 298: 121.
  • 35
    George TC, Mason LH, Ortaldo JR, Kumar V, Bennett M. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol 1999; 162: 20352043.
  • 36
    Raziuddin A, Longo DL, Mason L, Ortaldo JR, Bennett M, Murphy WJ. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J Immunol 1998; 160: 8794.
  • 37
    Shimizu E, Koike J, Wakao H et al. Role of a NK receptor, KLRE-1, in bone marrow allograft rejection: Analysis with KLRE-1-deficient mice. Blood 2004; 104: 781783.
  • 38
    Gonzalez S, Groh V, Spies T. Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol 2006; 298: 121138.
  • 39
    Lanier LL. NKG2D in innate and adaptive immunity. Adv Exp Med Biol 2005; 560: 5156.
  • 40
    Hamerman JA, Ogasawara K, Lanier LL. NK cells in innate immunity. Curr Opin Immunol 2005; 17: 2935.
  • 41
    Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier LL. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol 2005; 6: 938945.
  • 42
    Podack ER, Hengartner H, Lichtenheld MG. A central role of perforin in cytolysis? Annu Rev Immunol 1991; 9: 129157.
  • 43
    Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006; 214: 7391.
  • 44
    Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006; 107: 159166.
  • 45
    Voskoboinik I, Trapani JA. Addressing the mysteries of perforin function. Immunol Cell Biol 2006; 84: 6671.
    Direct Link:
  • 46
    Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized. J Exp Med 1987; 166: 14991509.
  • 47
    Miyawaki S, Nakamura Y, Suzuka H et al. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol 1994; 24: 429434.
  • 48
    Barber DL, Wherry EJ, Ahmed R. Cutting edge: Rapid in vivo killing by memory CD8 T cells. J Immunol 2003; 171: 2731.
  • 49
    Adams AB, Durham MM, Kean L et al. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J Immunol 2001; 167: 11031111.
  • 50
    Bajenoff M, Breart B, Huang AY et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 2006; 203: 619631.
  • 51
    Yokoyama WM. Specific and non-specific natural killer cell responses to viral infection. Adv Exp Med Biol 2005; 560: 5761.
  • 52
    Maxwell JR, Yadav R, Rossi RJ et al. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol 2006; 177: 234245.
  • 53
    Yu J, Wei M, Becknell B et al. Pro- and antiinflammatory cytokine signaling: Reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 2006; 24: 575590.
  • 54
    Tay CH, Yu LY, Kumar V, Mason L, Ortaldo JR, Welsh RM. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J Immunol 1999; 162: 718726.
  • 55
    Ho EL, Carayannopoulos LN, Poursine-Laurent J et al. Costimulation of multiple NK cell activation receptors by NKG2D. J Immunol 2002; 169: 36673675.
  • 56
    Regunathan J, Chen Y, Wang D, Malarkannan S. NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. Blood 2005; 105: 233240.